Spark Therapeutics, INC.
Biopharmaceutical/gene therapy company
Based in PA
🤖
AI Overview
With $1.4M in lobbying spend across 29 quarterly filings, Spark Therapeutics, INC. is a significant lobbying presence. They deploy 13 individual lobbyists
$1.4M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
13
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $120K |
| 2025 | $80K |
Lobbying Firms
BROWNSTEIN HYATT FARBER SCHRECK, LLP
What They Lobby For
- Issues related to the development of therapies for rare diseases
- Issues related to the development of therapies for rare diseases Patient Affordability Value and Efficiency Act
- Issues related to the development of therapies for rare diseases Patient Affordability Value and Efficiency Act
- Issues related to the development of gene therapies for rare diseases
- Issues related to the development of gene therapies for rare diseases S. 4204/ H.R. 2666 MVP ACT
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.